Print Page      Close Window     

Investors

SEC Filings

6-K
OBSEVA SA filed this Form 6-K on 03/30/2018
Entire Document
 


LOGO

 

Strategic Focus: Large populations with high unmet medical need & limited competition Age 15+ Adolescent & Young Adult Gynecology Oral Contraception Anti-Infectives Pregnancy Supplements OTC / Generics Age 15—Age 49 ObsEva Focus Uterine Fibroids Endometriosis Infertility- ART Preterm Labor Preeclampsia Age 50+ Menopause Menopause Symptoms Hormone Replacement Therapy Osteoporosis Generics / Innovation by Big Pharma